ADMA Biologics Inc (ADMA):企業の財務・戦略的SWOT分析

◆英語タイトル:ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH250214FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ADMA Biologics Inc (ADMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ADMA Biologics Inc (ADMA Biologics) is an integrated biopharmaceutical and specialty immunoglobulin company which develops, produces, and commercializes specialty biologics to treat immune deficiencies and prevent certain infectious diseases. The company develops RI-002, is a specialty plasma-derived, polyclonal, intravenous immune globulin, derived from human plasma containing naturally occurring polyclonal antibodies to treat Primary Immune Deficiency Disease. ADMA Biologics’ target treatment areas include bacterial infections, respiratory syncytial virus and primary immune deficiency diseases. It also operates bio centers which carry out plasma collection and offer blood plasma to manufacture the company’s products. ADMA Biologics is headquartered in Ramsey, New Jersey, the US.

ADMA Biologics Inc Key Recent Developments

Dec 09,2020: ADMA Biologics enters into $100 million credit facility loan amendment with perceptive advisors
Dec 01,2020: ADMA Biologics opens newest ADMA BioCenters plasma collection facility in Maryville, TN
Nov 05,2020: ADMA Biologics reports third quarter 2020 financial results and business highlights
Oct 21,2020: ADMA Biologics announces presentation on respiratory viral infections and new data on S. Pneumoniae at IDWeek 2020
Aug 05,2020: ADMA Biologics reports business highlights and second quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ADMA Biologics Inc – Key Facts
ADMA Biologics Inc – Key Employees
ADMA Biologics Inc – Key Employee Biographies
ADMA Biologics Inc – Major Products and Services
ADMA Biologics Inc – History
ADMA Biologics Inc – Company Statement
ADMA Biologics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ADMA Biologics Inc – Business Description
Product Category: License Revenue
Performance
Product Category: Product Revenue
Performance
Product Category: ADMA BioManufacturing
Overview
Performance
Product Category: Corporate
Performance
Product Category: Plasma Collection Center
Overview
Performance
R&D Overview
ADMA Biologics Inc – Corporate Strategy
ADMA Biologics Inc – SWOT Analysis
SWOT Analysis – Overview
ADMA Biologics Inc – Strengths
ADMA Biologics Inc – Weaknesses
ADMA Biologics Inc – Opportunities
ADMA Biologics Inc – Threats
ADMA Biologics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ADMA Biologics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 09, 2020: ADMA Biologics enters into $100 million credit facility loan amendment with perceptive advisors
Dec 01, 2020: ADMA Biologics opens newest ADMA BioCenters plasma collection facility in Maryville, TN
Nov 05, 2020: ADMA Biologics reports third quarter 2020 financial results and business highlights
Oct 21, 2020: ADMA Biologics announces presentation on respiratory viral infections and new data on S. Pneumoniae at IDWeek 2020
Aug 05, 2020: ADMA Biologics reports business highlights and second quarter 2020 financial results
Jul 06, 2020: ADMA Biologics opens its newest ADMA BioCenters plasma collection facility
Jun 23, 2020: ADMA Biologics announces Martha J. Demski elected to Board of Directors
May 21, 2020: ADMA Biologics commences collection of COVID-19 Plasma from recovered patients
May 06, 2020: ADMA Biologics reports first quarter 2020 financial results and highlights recent company progress
Apr 16, 2020: ADMA Biologics receives funding under Paycheck Protection Program
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ADMA Biologics Inc, Key Facts
ADMA Biologics Inc, Key Employees
ADMA Biologics Inc, Key Employee Biographies
ADMA Biologics Inc, Major Products and Services
ADMA Biologics Inc, History
ADMA Biologics Inc, Subsidiaries
ADMA Biologics Inc, Key Competitors
ADMA Biologics Inc, Ratios based on current share price
ADMA Biologics Inc, Annual Ratios
ADMA Biologics Inc, Annual Ratios (Cont...1)
ADMA Biologics Inc, Interim Ratios
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ADMA Biologics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ADMA Biologics Inc (ADMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cabot Energy Plc (CAB):石油・ガス:M&Aディール及び事業提携情報
    Summary Cabot Energy Plc (Cabot), formerly Northern Petroleum, is an independent upstream oil and gas company. It explores for, develops, and produces oil and natural gas; and trades assets. The company operates in onshore and offshore projects including gas producing fields and oil fields. Cabot's …
  • Illinois Tool Works Inc.:企業の戦略・SWOT・財務情報
    Illinois Tool Works Inc. - Strategy, SWOT and Corporate Finance Report Summary Illinois Tool Works Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析
    Summary Quantum Genomics SA (Quantum Genomics) is a bio pharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition ( …
  • AXA Equitable Life Insurance Company:企業の戦略・SWOT・財務分析
    AXA Equitable Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary AXA Equitable Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Grifols SA (GRF):製薬・医療:M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Medigen Biotechnology Corp (3176)-製薬・医療分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GROUPE ADEO SA:戦略・SWOT・企業財務分析
    GROUPE ADEO SA - Strategy, SWOT and Corporate Finance Report Summary GROUPE ADEO SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • H. Lundbeck AS (LUN)-製薬・医療分野:企業M&A・提携分析
    Summary H. Lundbeck A/S (Lundbeck), a subsidiary of The Lundbeck Foundation carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) related diseases including psychiatric and neurological disorders. Its products are …
  • Milliken & Co:企業の戦略的SWOT分析
    Milliken & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The Baltimore Life Insurance Company:企業の戦略・SWOT・財務情報
    The Baltimore Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Baltimore Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Oversea-Chinese Banking Corp Ltd:企業の戦略・SWOT・財務情報
    Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Business Development Bank Of Canada:企業の戦略・SWOT・財務分析
    Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report Summary Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Air China Limited:企業の戦略・SWOT・財務情報
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Dufry AG (DUFN):企業の財務・戦略的SWOT分析
    Dufry AG (DUFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • UIL Energy Ltd (UIL):石油・ガス:M&Aディール及び事業提携情報
    Summary UIL Energy Ltd (UIL Energy) is an oil and gas company. The company provides business activities such as exploration for reserves of both conventional and unconventional oil and natural gas plays in proven hydrocarbon basins in Western Australia. It offers portfolio such as gas and liquids th …
  • Uelzena eG:企業の戦略・SWOT・財務分析
    Uelzena eG - Strategy, SWOT and Corporate Finance Report Summary Uelzena eG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Incyte Corp (INCY):企業の財務・戦略的SWOT分析
    Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Naftna industrija Srbije ad (NIIS):石油・ガス:M&Aディール及び事業提携情報
    Summary Naftna industrija Srbije ad (NIS), a subsidiary of Gazprom Neft, is an integrated energy company that conducts oil and gas exploration, production and refining, and sales and distribution of a broad range of petroleum products. Its refined products include motor fuel, diesel fuel, heating oi …
  • Companhia Paranaense de Energia SA (CPLE6):電力:M&Aディール及び事業提携情報
    Summary Companhia Paranaense de Energia SA (Copel) is an integrated electric utility. It generates, transmits, distributes and sells electricity. The company produces electricity from hydro, wind, and thermal sources. Copel explores oil and natural gas; and distributes natural gas. It holds rights t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆